The global market for power transformers is anticipated to expand at a CAGR of 8.1% over the forecast period (2025–2033). The primary function of power transformers is to transport low-voltage generator electricity through distribution channels within the power grid network. It is a fundamental component of the electrical grid that facilitates the frequency-invariant transmission of electricity from one network to another.
The global market for powder coating equipment is expected to grow at a CAGR of 5.2% during the forecast period of 2025 to 2033. The rising demand for energy-efficient devices as a result of the depletion of non-renewable resources, as well as the rising demand for powder coatings characterized by ease of use, increased flexibility, high quality, and storage performance, are important factors driving market revenue growth.
The market for Porokeratosis Treatment is projected to expand at a CAGR of 7% during the forecast period of 2025 to 2033. Numerous factors, including an increase in renal transplant cases, improved reimbursement policies in developed nations, an increase in research funding, and intensifying competition among market participants, continue to contribute to the expansion of the global market.
The global market for point-of-care molecular diagnostics is anticipated to expand at a CAGR of 8.5% during the forecast period of 2025 and 2033. The rise of the point-of-care molecular diagnostics market is primarily driven by the increasing prevalence of infectious diseases and cancer, as well as the growing desire of end users for point-of-care molecular testing due to its attractive features. Medical personnel has long utilized molecular diagnostics in laboratories and other healthcare settings.
Pinatex Market is anticipated to develop at a CAGR of 6.5% during the forecast period of 2025 to 2033. As customers become increasingly concerned of the influence that their purchases have on the environment and animal welfare, it is anticipated that the market for Pinatex will expand at a high rate over the course of the forecast period.
The global market for pet DNA testing market is expected to grow at a CAGR of 10% during the forecast period of 2025 to 2033. The expansion of the market is being driven by a number of factors, including rising rates of pet ownership, rising consumer interest in genomics, rising levels of research and development activities carried out by key companies and academic researchers, and rising levels of consumer awareness and demand for DNA testing kits for pets.
The period panty market is projected to expand at a CAGR of 18% during the forecast period of 2025 to 2033. The market is primarily driven by the increasing awareness of menstrual hygiene and the different activities and programs implemented by organizations. For instance, the collaboration between UNICEF and local governments, communities, and schools to conduct research and disseminate information about menstruation has fostered the adoption of hygienic practices conducive to the elimination of societal taboos.
The global percutaneous coronary intervention guidance devices market is expected to expand at a CAGR of 6.5% during the forecast period of 2025 to 2033. Guidance devices for percutaneous coronary intervention are utilized in the diagnosis and treatment of cardiovascular diseases.
The global peptide microarray market is projected to expand at a CAGR of 4.5% during the forecast period of 2025 to 2033. In the fields of proteomics and clinical assays, peptide microarrays are a robust technique for tracking the binding activity, histone-modifying enzymes, and protein linkage function on a large scale. The rising incidence of cancer and advances in technology are the primary factors driving the industry's expansion worldwide.
Pediatric congenital heart surgery has been performed using pediatric perfusion devices for the past four decades. Each year, over 18,000 pediatric open-heart surgeries are performed in North America. The majority of pediatric open heart surgeries are performed on infants younger than one year. A congenital ventricular septal defect is the leading cause of pediatric bypass.
